APA (7th ed.) Citation

Nandula, S. R., Jain, A., & Sen, S. Cardio-renal effect of dapagliflozin and dapagliflozin- saxagliptin combination on CD34 + ve hematopoietic stem cells (HSCs) and podocyte specific markers in type 2 diabetes (T2DM) subjects: A randomized trial. BMC.

Chicago Style (17th ed.) Citation

Nandula, Seshagiri Rao, Arad Jain, and Sabyasachi Sen. Cardio-renal Effect of Dapagliflozin and Dapagliflozin- Saxagliptin Combination on CD34 + ve Hematopoietic Stem Cells (HSCs) and Podocyte Specific Markers in Type 2 Diabetes (T2DM) Subjects: A Randomized Trial. BMC.

MLA (9th ed.) Citation

Nandula, Seshagiri Rao, et al. Cardio-renal Effect of Dapagliflozin and Dapagliflozin- Saxagliptin Combination on CD34 + ve Hematopoietic Stem Cells (HSCs) and Podocyte Specific Markers in Type 2 Diabetes (T2DM) Subjects: A Randomized Trial. BMC.